Volunteer for a clinical trial and make a difference in the health of the nation

NHLBI researchers, in partnership with Loyola University Chicago, seek individuals with kidney cancer for a new treatment study using gene therapy. Gene therapy is a process of modifying a person's immune system to create tumor fighting cells to recognize and kill their cancer. Study-related procedures, tests, and medications are provided at no cost. SELF REFERRALS WELCOME. Refer to Study #18-H-0012.

NIAAA invites healthy volunteers, 21-60 years of age to participate in a study researching if a gene and smoking affect drinking. Volunteers should be healthy, drug-free, and not seeking treatment for alcohol-related problems. Research participation includes 3 outpatient visits which consist of alcohol consumption, brain scans (MRI), blood draws, and filling out questionnaires. Compensation may be provided. Refer to Study #17-AA-0171.

NHLBI researchers need volunteers at least 4 years old with Fanconi anemia to participate in a study looking to help investigate a treatment to improve blood counts. Compensation for travel is provided. Study-related tests are provided at no cost and results are shared with you and your doctor. Refer to Study #17-H-0121.

CLL patients, 'team-up' in your fight against leukemia. NCI physician scientists are conducting a study using IL-15 in combination with obinutuzumab with hopes of discovering effective treatments. Participate, there is no cost for treatments & travel assistance within the U.S. available. Refer to Study #19-C-0024.

ALS research at NINDS to test the effects of a combination of 4 drugs on the HERV-K levels in patients with elevated blood levels, and to see if this affects their ALS symptoms. Refer to Study #15-N-0126.

Faced with glioblastoma (GBM) that has returned despite standard treatments? Partner with NINDS researchers in a study designed to look at the effects of two research drugs on the brain's immune system in people whom have had a return of GBM brain tumor. We will also look at the effects of these drugs on the brain tumor. All research related care and experimental treatment provided at no cost. Refer to Study #18-N-0077.

NIDDK seeks healthy normal weight men, 18-35, to participate in a research study. Doctors want to learn how the body burns energy at different temperatures. Participants will have a 17-day inpatient stay in the Metabolic Clinical Research Unit of the Clinical Center with weekends off. Compensation is provided. Refer to Study #13-DK-0200 cohort 2.

NIH-CC seeks infants 3-12 months and young children 1-5 years of age who are developing typically. The study aims to learn more about the motor skill and brain development of young children who are at high-risk for or diagnosed with Cerebral Palsy (CP) and Autism Spectrum Disorder (ASD) compared to young children with typical development. The results of this study may assist with better methods for early diagnosis as well as improved treatment for children with CP and ASD. The results of this study may eventually assist with better methods for early diagnosis as well as improved treatment for children with autism. This is an outpatient visit and all the minor participant require parents' permission to participate. Refer to Study #18-CC-0052.

National Cancer Institute researchers are testing a new treatment in people with liver cancer (hepatocellular carcinoma). The treatment uses nivolumab (immune therapy) given in combination with tadalafil and vancomycin (an antibiotic that changes the gut bacteria) to see if the tumors shrink. Participants do not pay for tests, treatments, or procedures. Travel may be reimbursed. Refer to Study #19-C-0033.

If you or someone you know is drinking too much, the NIH may be able to help. NIAAA conducts studies on how alcohol affects the body and are looking for new ways to treat alcohol problems. If you qualify, you can receive alcoholism treatment at no-cost while you participate in our research. Compensation may also be provided. Refer to Study #14-AA-0181.